What's in Farmoquimica S.A.'s pipeline?

Farmoquimica S.A. has 5 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Farmoquimica S.A.'s portfolio?

Top competitors by shared drug class: Erasmus Medical Center, Faes Farma, S.A., Federal University of São Paulo, Genentech, Inc., Merck Sharp & Dohme LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/farmoquimica-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Farmoquimica S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Farmoquimica S.A. pipeline: 2 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Cipro HC	Cipro HC	marketed
Hidra1	Hidra1	marketed	H1 receptor antagonist	H1 receptor	Allergy
Dolamin Flex	Dolamin Flex	phase 3
Ciprofloxacin HCl and Hydrocortisone	Ciprofloxacin HCl and Hydrocortisone	phase 3	Fluoroquinolone antibiotic + corticosteroid combination	Bacterial DNA gyrase and topoisomerase IV; glucocorticoid receptor	Otology / Infectious Disease
Tandrilax	Tandrilax	phase 3			Other

Therapeutic area mix

Allergy · 1
Other · 1
Otology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Erasmus Medical Center · 1 shared drug class
Faes Farma, S.A. · 1 shared drug class
Federal University of São Paulo · 1 shared drug class
Genentech, Inc. · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
NTC srl · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Farmoquimica S.A.:

Cite this brief

Drug Landscape (2026). Farmoquimica S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/farmoquimica-s-a. Accessed 2026-05-16.